Table 2.

Coefficient of variance of the metabolic profile of the study population based on retinopathy incidence; data are presented as mean ± SD.

		Developed retinopathy	Did not develop retinopathy	p-value
Weight		0.07 ± 0.21	0.06 ± 0.18	0.646
Systolic blood pressure		0.10 ± 0.05	0.10 ± 0.10	0.804
Diastolic blood pressure		0.10 ± 0.07	0.10 ± 0.09	0.880
FBS	Total	0.25 ± 0.11	0.21 ± 0.11	<0.001
	≤130	0.24 ± 0.12	0.21 ± 0.11	0.102
	≥130	0.26 ± 0.10	0.22 ± 0.11	<0.001
2hPP	Total	0.26 ± 0.10	0.24 ± 0.10	<0.001
	≤180	0.28 ± 0.11	0.23 ± 0.11	0.053
	≥180	0.26 ± 0.10	0.24 ± 0.10	0.002
HbA1c	Total	0.11 ± 0.09	0.10 ± 0.09	0.420
	≤7.5	0.11 ± 0.03	0.10 ± 0.05	0.118
	≥7.5	0.11 ± 0.11	0.10 ± 0.13	0.759
Total cholesterol		0.18 ± 0.18	0.15 ± 0.06	0.002
HDL-c		0.15 ± 0.07	0.14 ± 0.06	0.060
LDL-c		0.24 ± 0.09	0.23 ± 0.11	0.565
TG		0.28 ± 0.11	0.27 ± 0.12	0.217
Creatinine		0.21 ± 0.12	0.19 ± 0.11	0.003
Uric acid		0.18 ± 0.19	0.16 ± 0.15	0.171
Albuminuria		0.73 ± 0.31	0.69 ± 0.33	0.108

FBS, fasting blood sugar; 2hPP, 2-h post-prandial blood glucose level; HbA1C, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; BMI, body mass index.